RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재후보

      Bidirectional ephrin signaling in bone

      한글로보기

      https://www.riss.kr/link?id=A107043000

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      The interaction between ephrin ligands (efn) and their receptors (Eph) is capable of inducing forward signaling, from ligand to receptor, as well as reverse signaling, from receptor to ligand. The ephrins are widely expressed in many tissues, where th...

      The interaction between ephrin ligands (efn) and their receptors (Eph) is capable of inducing forward signaling, from ligand to receptor, as well as reverse signaling, from receptor to ligand. The ephrins are widely expressed in many tissues, where they mediate cell migration and adherence, properties that make the efn-Eph signaling critically important in establishing and maintaining tissue boundaries. The efn-Eph system has also received considerable attention in skeletal tissues, as ligand and receptor combinations are predicted to mediate interactions between the different types of cells that regulate bone development and homeostasis. This review summarizes our current understanding of efn-Eph signaling with a particular focus on the expression and functions of ephrins and their receptors in bone.

      © 2016 The Korean Society of Osteoporosis. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

      더보기

      참고문헌 (Reference)

      1 Wieland I, "Twenty-six novel EFNB1 mutations in familial and sporadic craniofrontonasal syndrome (CFNS)" 26 : 113-118, 2005

      2 Kwan Tat S, "Treatment with ephrin B2 positively impacts the abnormal metabolism of human osteoarthritic chondrocytes" 11 : R119-, 2009

      3 Cheng S, "Transgenic overexpression of ephrin B1 in bone cells promotes bone formation and an anabolic response to mechanical loading in mice" 8 : e69051-, 2013

      4 Martin-Rendon E, "Transcriptional profiling of human cord blood CD133þ and cultured bone marrow mesenchymal stem cells in response to hypoxia" 1003-1012, 2007

      5 Eppig JT, "The mouse genome database (MGD): facilitating the mouse as a model for human biology and disease" 43 : D726-D736, 2015

      6 Flanagan JG, "The ephrins and Eph receptors in neural development" 21 : 309-345, 1998

      7 Campbell TN, "The Eph receptor/ephrin system: an emerging player in the invasion game" 10 : 61-66, 2008

      8 Shenolikar S, "Targeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate cotransporter type IIa and renal phosphate wasting" 99 : 11470-11475, 2002

      9 Cheng S, "Targeted disruption of ephrin B1 in cells of myeloid lineage increases osteoclast differentiation and bone resorption in mice" 3 : e32887-, 2012

      10 Hong JH, "TAZ: a beta-catenin-like molecule that regulates mesenchymal stem cell differentiation" 5 : 176-179, 2006

      1 Wieland I, "Twenty-six novel EFNB1 mutations in familial and sporadic craniofrontonasal syndrome (CFNS)" 26 : 113-118, 2005

      2 Kwan Tat S, "Treatment with ephrin B2 positively impacts the abnormal metabolism of human osteoarthritic chondrocytes" 11 : R119-, 2009

      3 Cheng S, "Transgenic overexpression of ephrin B1 in bone cells promotes bone formation and an anabolic response to mechanical loading in mice" 8 : e69051-, 2013

      4 Martin-Rendon E, "Transcriptional profiling of human cord blood CD133þ and cultured bone marrow mesenchymal stem cells in response to hypoxia" 1003-1012, 2007

      5 Eppig JT, "The mouse genome database (MGD): facilitating the mouse as a model for human biology and disease" 43 : D726-D736, 2015

      6 Flanagan JG, "The ephrins and Eph receptors in neural development" 21 : 309-345, 1998

      7 Campbell TN, "The Eph receptor/ephrin system: an emerging player in the invasion game" 10 : 61-66, 2008

      8 Shenolikar S, "Targeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate cotransporter type IIa and renal phosphate wasting" 99 : 11470-11475, 2002

      9 Cheng S, "Targeted disruption of ephrin B1 in cells of myeloid lineage increases osteoclast differentiation and bone resorption in mice" 3 : e32887-, 2012

      10 Hong JH, "TAZ: a beta-catenin-like molecule that regulates mesenchymal stem cell differentiation" 5 : 176-179, 2006

      11 Hong JH, "TAZ, a transcriptional modulator of mesenchymal stem cell differentiation" 309 : 1074-1078, 2005

      12 Adams RH, "Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis" 13 : 295-306, 1999

      13 Robinson V, "Roles of Eph receptors and ephrins in neural crest pathfinding" 290 : 265-274, 1997

      14 Zhang J, "Role of the ephrin and eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system" 208 : 453-461, 2006

      15 Kim J, "Rewiring of PDZ domain-ligand interaction network contributed to eukaryotic evolution" 8 : e1002510-, 2012

      16 Kuijper S, "Regulation of angiogenesis by Ephephrin interactions" 17 : 145-151, 2007

      17 Ardura JA, "Regulation of G protein-coupled receptor function by Naþ/Hþ exchange regulatory factors" 63 : 882-900, 2011

      18 Mao Y, "Preliminary identification of potential PDZ-domain proteins downstream of ephrin B2 during osteoclast differentiation of RAW264.7 cells" 27 : 669-677, 2011

      19 Ivarsson Y, "Plasticity of PDZ domains in ligand recognition and signaling" 586 : 2638-2647, 2012

      20 Beuming T, "PDZBase:a protein-protein interaction database for PDZ-domains" 21 : 827-828, 2005

      21 Yang JY, "Osteoblasttargeted overexpression of TAZ increases bone mass in vivo" 8 : e56585-, 2013

      22 Hong D, "Osteoblastogenic effects of dexamethasone through upregulation of TAZ expression in rat mesenchymal stem cells" 116 : 86-92, 2009

      23 Wang B, "NHERF1 regulation of PTH-dependent bimodal Pi transport in osteoblasts" 52 : 268-277, 2013

      24 Stadler HS, "Loss of Eph-receptor expression correlates with loss of cell adhesion and chondrogenic capacity in Hoxa13 mutant limbs" 128 : 4177-4188, 2001

      25 Naruse-Nakajima C, "Involvement of EphA2 in the formation of the tail notochord via interaction with ephrinA1" 102 : 95-105, 2001

      26 Wada N, "Glycosylphosphatidylinositol-anchored cell surface proteins regulate positionspecific cell affinity in the limb bud" 202 : 244-252, 1996

      27 Duffy SL, "Generation and characterization of EphA1 receptor tyrosine kinase reporter knockout mice" 46 : 553-561, 2008

      28 Liu H, "EphrinBmediated reverse signaling controls junctional integrity and proinflammatory differentiation of endothelial cells" 112 : 151-163, 2014

      29 Takyar FM, "EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone" 28 : 912-925, 2013

      30 Tonna T, "EphrinB2 signaling in osteoblasts promotes bone mineralization by preventing apoptosis" 28 : 4482-4496, 2014

      31 Allan EH, "EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts" 23 : 1170-1181, 2008

      32 Palmer A, "EphrinB phosphorylation and reverse signaling:regulation by Src kinases and PTP-BL phosphatase" 9 : 725-737, 2002

      33 Kao T-J, "Ephrin-mediated cis-attenuation of Eph receptor signaling is essential for spinal motor axon guidance" 71 : 76-91, 2011

      34 Gale NW, "Ephrin-B2 selectivity marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells" 230 : 151-160, 2001

      35 Davy A, "Ephrin-B2 forward signaling regulates somite patterning and neural crest cell development" 304 : 182-193, 2007

      36 Foo SS, "Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly" 124 : 161-173, 2006

      37 Wang Y, "Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis" 465 : 483-486, 2010

      38 Huynh-Do U, "Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis" 115 : 3073-3081, 2002

      39 Bush JO, "Ephrin-B1 regulates axon guidance by reverse signaling through a PDZ-dependent mechanism" 23 : 1586-1599, 2009

      40 Bush JO, "Ephrin-B1 forward signaling regulates craniofacial morphogenesis by controlling cell proliferation across Eph-ephrin boundaries" 24 : 2068-2080, 2010

      41 Davy A, "Ephrin-B1 forward and reverse signaling are required during mouse development" 18 : 572-583, 2004

      42 Benson MD, "Ephrin-B stimulation of calvarial bone formation" 241 : 1901-1910, 2012

      43 Davy A, "Ephrin signaling in vivo: look both ways" 232 : 1-10, 2005

      44 San Miguel S, "Ephrin reverse signaling controls palate fusion via a PI3kinase-dependent mechanism" 240 : 357-364, 2011

      45 Nagano K, "Ephrin receptor A10 is a promising drug target potentially useful for breast cancers including triple negative breast cancers" 189 : 72-79, 2014

      46 Wang Y, "Ephrin B2/EphB4 mediates the actions of IGF-I signaling in regulating endochondral bone formation" 29 : 1900-1913, 2014

      47 Xing W, "Ephrin B1 regulates bone marrow stromal cell differentiation and bone formation by influencing TAZ transactivation via complex formation with NHERF1" 30 : 711-721, 2010

      48 Nguyen TM, "EphB4 expressing stromal cells exhibit an enhanced capacity for hematopoietic stem cell maintenance" 33 : 2838-2849, 2015

      49 Arthur A, "EphB4 enhances the process of endochondral ossification and inhibits remodeling during bone fracture repair" 926-935, 2013

      50 Risley M, "EphB2 and EphB3 forward signaling are required for palate development" 126 : 230-239, 2009

      51 Nguyen TM, "EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells" 22 : 2751-2764, 2013

      52 Stiffel V, "EphA4 is a novel negative regulator of osteoclast activity" 29 : 804-819, 2014

      53 Ting M-C, "EphA4 as an effector of Twist1 in the guidance of osteogenic precursor cells during calvarial bone growth and in craniosynostosis" 136 : 855-864, 2009

      54 Miao H, "EphA receptor signaling-Complexity and emerging themes" 23 : 16-25, 2012

      55 Luxey M, "Eph:ephrin-B1 forward signaling controls fasciculation of sensory and motor axons" 383 : 264-274, 2013

      56 Arthur A, "Eph/ephrin-B interactions mediate human MSC attachment, migration and osteochondral differentiation" 48 : 533-542, 2011

      57 Arvanitis D, "Eph/ephrin signaling: networks" 22 : 416-429, 2008

      58 Klein R, "Eph/ephrin signaling during development" 139 : 4105-4109, 2012

      59 Stark DA, "Eph/ephrin interactions modulate muscle satellite cell motility and patterning" 138 : 5279-5289, 2011

      60 Pasquale EB, "Eph receptors and ephrins in cancer: bidirectional signaling and beyond" 10 : 165-180, 2010

      61 Himanen JP, "Eph receptors and ephrins" 35 : 130-134, 2003

      62 Edwards CM, "Eph receptors and ephrin signaling pathways:a role in bone homeostasis" 5 : 263-272, 2008

      63 Kitamura T, "Ehnacement of lymphocyte migration and cytokine production by ephrinB1 system in rheumatoid arthritis" 294 : C189-C196, 2008

      64 Sims NA, "EPHs and ephrins: many pathways to regulate osteoblasts and osteoclasts" 7 : 304-313, 2010

      65 Genander M, "Dissociation of EphB2 signaling pathways mediating progenitor cell proliferation and tumor suppression" 139 : 679-692, 2009

      66 Compagni A, "Control of skeletal patterning by ephrinB1-EphB interactions" 5 : 217-230, 2003

      67 Kesavan C, "Conditional disruption of IGF-I gene in type 1a collagen-expressing cells shows an essential role of IGF-I in skeletal anabolic response to loading" 301 : 1191-1197, 2011

      68 Marquardt T, "Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains" 121 : 127-139, 2005

      69 Tonna S, "Chondrocytic ephrinB2 promotes cartilage destruction by osteoclasts in endochondral ossification" 143 : 648-657, 2016

      70 Merrill AE, "Cell mixing at a neural crest-mesoderm boundary and deficient ephrin-Eph signaling in the pathogenesis of craniosynostosis" 15 : 1319-1328, 2006

      71 Matsuo K, "Bone cell interactions through Eph/ephrin. Bone modeling, remodeling and associated diseases" 6 : 148-156, 2012

      72 Cheng N, "Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis" 1 : 2-11, 2002

      73 Irie N, "Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis" 284 : 14637-14644, 2009

      74 Zhao C, "Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis" 4 : 111-121, 2006

      75 Laussu J, "Beyond boundaries-Eph/ephrin signaling in neurogenesis" 8 : 349-359, 2014

      76 Shimizu E, "Alendronate affects osteoblast functions by crosstalk through ephrinB1/EphB" 91 : 268-274, 2012

      77 Kwan Tat S, "Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts" 58 : 3820-3830, 2008

      78 Coulthard MG, "4Eph/ephrin signaling in injury and inflammation" 181 : 1493-1503, 2012

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 재인증평가 신청대상 (재인증)
      2020-01-01 평가 등재학술지 선정 (재인증) KCI등재
      2018-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      2017-12-01 평가 등재후보 탈락 (계속평가)
      2016-05-20 통합 KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.1 0.1 0.08
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.06 0.07 0.271 0.03
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼